Lobbying

International Aids Vaccine Initiative's latest lobbying report covers Q3 2025, at $10K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Foreign Relations.

International Aids Vaccine Initiative

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

International Aids Vaccine Initiative lobbying by quarter
International Aids Vaccine Initiative lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$70K1
Q2 2023$70K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$10K1
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Budget and appropriations$200K · 12 reports
  • Foreign relations$200K · 12 reports
  • Health issues$200K · 12 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES12 reports
  • SENATE12 reports
  • State, Dept of (DOS)12 reports
  • White House Office12 reports
  • Executive Office of the President (EOP)9 reports
  • U.S. Agency for International Development (USAID)9 reports

Firms it paid

Firm
Kyle House Group$600K12 quarters

Former officials lobbying for it

Former position
JULIAN FLEISCHMANSenior Legislative Assistant, Rep. Peter Meijer; Legislative Assistant, Rep. Brian MastQ3 2025
MICHAEL MILLERPolicy Director, U.S. Senate Committee on Foreign Relations; Senior Advisor, Office of the U.S. Secretary HHS; Deputy Assistant Administrator for Global Health, USAID; Director for African Affairs,NSC; Legislative Assistant, Senator Bill FristQ3 2025

Lobbying reports

Filed by
25/10/23for Q3 2025Kyle House Group$10K
25/07/21for Q2 2025Kyle House Group$50K
25/04/18for Q1 2025Kyle House Group$50K
25/01/21for Q4 2024Kyle House Group$50K
24/10/18for Q3 2024Kyle House Group$50K
24/07/18for Q2 2024Kyle House Group$50K
24/04/18for Q1 2024Kyle House Group$50K
24/01/22for Q4 2023Kyle House Group$50K
23/10/20for Q3 2023Kyle House Group$50K
23/07/20for Q2 2023Kyle House Group$70K
23/04/20for Q1 2023Kyle House Group$70K
23/01/20for Q4 2022Kyle House Group$50K